You act as a paraphrase tool. Your role involves understanding the provided text…
- User
System: You act as a paraphrase tool. Your role involves understanding the provided text and then providing a positive example that keeps the original meaning of the text unchanged while using synonyms, interchanging, adding or removing words or sentences, and then provide a negative example where the meaning of the original text is at its opposite. Output your response with the following format : Positive : Negative :
User: We have a significant amount of indebtedness, which could materially adversely affect our operating results, financial condition and liquidity. As of December 31, 2020, we had approximately 1.0 billion. While we currently do not have any amounts drawn under the credit facility nor any commercial paper issued under the commercial paper program, we may incur indebtedness under these arrangements in the future. We may incur substantial additional debt from time to time to finance working capital, capital expenditures, investments or acquisitions, or for other purposes. If we do so, the risks related to our high level of debt could intensify. Specifically, our high level of debt could have important consequences, including: •making it more difficult for us to satisfy our obligations with respect to our debt; •limiting our ability to obtain additional financing to fund future working capital, capital expenditures, business development or other general corporate requirements, including dividends; •increasing our vulnerability to general adverse economic and industry conditions; •exposing us to the risk of increased interest rates as certain of our borrowings are and may in the future be at variable rates of interest; •limiting our flexibility in planning for and reacting to changes in the animal health Assistant:
- Assistant
Positive: We have a substantial level of debt, which could significantly and negatively impact our financial performance, stability, and cash flow. As of December 31, 2020, our total outstanding unsecured debt was roughly 1.0 billion. While we currently haven’t utilized the credit facility or issued commercial paper under this program, we might incur debt through these instruments in the future. We may periodically take on considerable additional debt to finance working capital, capital investments, acquisitions, or other needs. Should we do this, the risks associated with our significant level of debt might increase. Specifically, our substantial debt could lead to important outcomes such as: •making it harder for us to fulfill our debt obligations; •restricting our ability to secure extra funding for upcoming working capital, capital investments, expansion, or other essential corporate necessities, including dividends; •making us more susceptible to unfavorable economic and industry shifts; •subjecting us to potential risks from rising interest rates, as a portion of our liabilities is and could be in the future affected by variable interest rates; and •restricting our adaptability in preparing for and responding to changes in the animal health sector.
Negative: We have minimal debt, which positively influences our financial performance, stability, and available liquidity. As of December 31, 2020, we had a total unsecured debt considerably below $7.25 billion. Additionally, we don't have agreements for a revolving credit facility or a commercial paper program at this time. We have no plans to incur indebtedness under these arrangements moving forward. If we do take on debt, it will be minimal and won't intensify any related risks. Specifically, our low level of debt could result in favorable conditions such as: •making it easy for us to meet obligations related to any debt; •enhancing our potential to secure further financing for future growth, capital expenditures, and other corporate needs, inclusive of dividends; •increasing our resilience against negative economic and industry climates; •protecting us from the risk of rising interest rates since our debt levels are low and stable; and •enhancing our strategic flexibility in adapting to changes in the animal health industry.